Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Frontiers in Oncology|August 17, 2023
Predictive signature of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer integrating mRNA expression, taxonomic subtypes, and clinicopathological featuresAlbert Font, Montserrat Domenech, Jose Luis Ramirez, et al.
Scientific Reports|August 2, 2019
Pyrosequencing versus methylation-specific PCR for assessment of MGMT methylation in tumor and blood samples of glioblastoma patientsAnna Estival, Carolina Sanz, Jose-Luis Ramirez, et al.
JAMA Dermatology|January 12, 2018
Early Genetic Diagnosis of Neurofibromatosis Type 2 From Skin Plaque Plexiform Schwannomas in ChildhoodElisabeth Castellanos, Adrià Plana, Cristina Carrato, et al.
Cancers|July 9, 2020
Immunohistochemistry-Based Taxonomical Classification of Bladder Cancer Predicts Response to Neoadjuvant ChemotherapyAlbert Font, Montserrat Domènech, Raquel Benítez, et al.
Plos One|January 26, 2017
A Comparison of RNA-Seq Results from Paired Formalin-Fixed Paraffin-Embedded and Fresh-Frozen Glioblastoma Tissue SamplesAnna Esteve-Codina, Oriol Arpi, Maria Martinez-García, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 26, 2025
Periventricular gliomas: Evaluation of the risks associated with ventricular opening in two cohorts-one prospective with TachoSil® for ventricular sealing and the other without it retrospectivePilar Teixidor-Rodríguez, Ferran Brugada-Bellsolà, Sebastián Menéndez-Girón, et al.
Cancers|October 2, 2020
Complete Loss of EPCAM Immunoexpression Identifies EPCAM Deletion Carriers in MSH2-Negative Colorectal NeoplasiaMíriam Cuatrecasas, Iñigo Gorostiaga, Cristina Riera, et al.
Cancers|February 24, 2024
The C250T Mutation of TERTp Might Grant a Better Prognosis to Glioblastoma by Exerting Less Biological Effect on Telomeres and Chromosomes Than the C228T MutationTeresa Gorria, Carme Crous, Estela Pineda, et al.
Cancer Medicine|November 7, 2017
Pseudoprogression as an adverse event of glioblastoma therapyCarmen Balaña, Jaume Capellades, Estela Pineda, et al.
Biomedicines|February 25, 2022
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic ResponseJoan Gil, Montserrat Marques-Pamies, Elena Valassi, et al.
Pageof 6